Merck licenses innovative anti-cancer therapy LM-299 from LaNova Medicines
In a strategic move to broaden its oncology portfolio, Merck & Co., Inc. (NYSE: MRK), recognized globally as MSD outside the U.S. and Canada, has ... Read More
Shanghai crumbles as most powerful typhoon in 75 years brings city to its knees
Shanghai came to a standstill as Typhoon Bebinca, the most powerful storm in 75 years, hit the city on Monday, September 16, 2024, with winds ... Read More
North Field South Project : QatarEnergy forges new LNG partnership with Sinopec
In a pivotal agreement poised to bolster the LNG industry, QatarEnergy has inked a partnership accord with China Petrochemical Corporation (Sinopec) for the North Field ... Read More
Shandong earthquake: Tremors disrupt train services, buildings crumble
In a shocking event that left China's eastern province of Shandong in devastation, a magnitude 5.5 earthquake struck with fury, injuring 21 unsuspecting residents and ... Read More
Pony.ai, Toyota, and GAC Toyota form driverless robotaxis joint venture
Pony.ai, a Chinese autonomous driving company, Toyota Motor (China) Investment Co., Ltd. (TMCI), and GAC Toyota Motor Co., Ltd. (GTMC) held a joint venture signing ... Read More
Viva Biotech sells 24% stake in CRO business Viva Shanghai for $150m
Viva Biotech Holdings Group has announced the fundraising of nearly $150 million by transferring about 24% of its equity interest in Viva Shanghai, its chief ... Read More
CLPS subsidiary JAJI to develop smart cockpit for safer intelligent vehicles
Hong Kong-based CLPS Incorporation has announced that its majority-owned subsidiary, JAJI (Shanghai), has initiated the development of a new smart cockpit product aimed at enhancing ... Read More
Pulse Medical μFR system gets FDA breakthrough status for pan-vascular diagnosis
Pulse Medical Technology has announced that its fourth-generation μFR system has received breakthrough device designation from the US Food and Drug Administration (FDA) for pan-vascular ... Read More
LaNova Medicines, AstraZeneca sign $600m worth licensing deal for LM-305
LaNova Medicines has signed an exclusive license deal worth over $600 million for its pre-clinical stage antibody drug conjugate (ADC) called LM-305 with AstraZeneca. LM-305 ... Read More
G7 raises $200m for providing software for Chinese road freight industry
G7, a software service provider for the Chinese road freight industry, has raised $200 million in a new funding round led by Shanghai-based private equity ... Read More